There's never a bad time to step into a quality dividend name, but there are certainly better times than others.
Pro Medicus has renewed its major contract with Northwestern Medicine, locking in higher fees and strengthened client ties for the next five years. The post Pro Medicus locks in 5-year, $37m ...
Telix Pharmaceuticals has announced a US$40m strategic collaboration with Regeneron for innovative radiopharmaceutical cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results